Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo

Exopolysaccharides act as mediators of cross-talk between probiotics and the host. Here, we found that EPS derived from probiotic Lactobacillus casei WXD030 strain (L-EPS) could modulate immune responses in vitro and in vivo. L-EPS could significantly enhance the proliferation and phagocytic activit...

Full description

Bibliographic Details
Main Authors: Lei Xiu, Haochi Zhang, Zhongpeng Hu, Yanchen Liang, Shuai Guo, Ming Yang, Ruiping Du, Xiao Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Food and Agricultural Immunology
Subjects:
Online Access:http://dx.doi.org/10.1080/09540105.2018.1513994
_version_ 1818840096891207680
author Lei Xiu
Haochi Zhang
Zhongpeng Hu
Yanchen Liang
Shuai Guo
Ming Yang
Ruiping Du
Xiao Wang
author_facet Lei Xiu
Haochi Zhang
Zhongpeng Hu
Yanchen Liang
Shuai Guo
Ming Yang
Ruiping Du
Xiao Wang
author_sort Lei Xiu
collection DOAJ
description Exopolysaccharides act as mediators of cross-talk between probiotics and the host. Here, we found that EPS derived from probiotic Lactobacillus casei WXD030 strain (L-EPS) could modulate immune responses in vitro and in vivo. L-EPS could significantly enhance the proliferation and phagocytic activity as well as induce the production of NO, TNF-α, IL-1β and IL-6 in RAW264.7 cells. Furthermore, L-EPS could induce the maturation of BMDCs. In addition, L-EPS could largely increase the titres of OVA-specific antibodies and markedly enhanced T cell proliferation. Notably, L-EPS also increased expression of IL-4 and INF-γ expression in CD4+T cells. Consistently, when used as an adjuvant in vivo with the foot-and-mouth disease vaccine, L-EPS largely enhanced the FMDV-specific antibody production. Collectively, these results suggested that L-EPS derived from probiotic L. casei strain had adjuvant activity, which may be a safe and efficacious adjuvant candidate suitable for a wide spectrum of prophylactic and therapeutic vaccines.
first_indexed 2024-12-19T04:04:46Z
format Article
id doaj.art-7c3d42cc2c04429bac7b4c46a1104ec4
institution Directory Open Access Journal
issn 0954-0105
1465-3443
language English
last_indexed 2024-12-19T04:04:46Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Food and Agricultural Immunology
spelling doaj.art-7c3d42cc2c04429bac7b4c46a1104ec42022-12-21T20:36:33ZengTaylor & Francis GroupFood and Agricultural Immunology0954-01051465-34432018-01-012911086110510.1080/09540105.2018.15139941513994Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivoLei Xiu0Haochi Zhang1Zhongpeng Hu2Yanchen Liang3Shuai Guo4Ming Yang5Ruiping Du6Xiao Wang7State Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityState Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityState Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityState Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityState Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityThe Biodesign Institute, Arizona State UniversityAnimal Nutrition Institute, Agriculture and Animal Husbandry Academy of Inner MongoliaState Key Laboratory of Reproductive Regulation & Breding of Grassland Livestock, School of life Science, Inner Mongolia UniversityExopolysaccharides act as mediators of cross-talk between probiotics and the host. Here, we found that EPS derived from probiotic Lactobacillus casei WXD030 strain (L-EPS) could modulate immune responses in vitro and in vivo. L-EPS could significantly enhance the proliferation and phagocytic activity as well as induce the production of NO, TNF-α, IL-1β and IL-6 in RAW264.7 cells. Furthermore, L-EPS could induce the maturation of BMDCs. In addition, L-EPS could largely increase the titres of OVA-specific antibodies and markedly enhanced T cell proliferation. Notably, L-EPS also increased expression of IL-4 and INF-γ expression in CD4+T cells. Consistently, when used as an adjuvant in vivo with the foot-and-mouth disease vaccine, L-EPS largely enhanced the FMDV-specific antibody production. Collectively, these results suggested that L-EPS derived from probiotic L. casei strain had adjuvant activity, which may be a safe and efficacious adjuvant candidate suitable for a wide spectrum of prophylactic and therapeutic vaccines.http://dx.doi.org/10.1080/09540105.2018.1513994exopolysaccharideslactobacillus caseiadjuvantimmune responses
spellingShingle Lei Xiu
Haochi Zhang
Zhongpeng Hu
Yanchen Liang
Shuai Guo
Ming Yang
Ruiping Du
Xiao Wang
Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
Food and Agricultural Immunology
exopolysaccharides
lactobacillus casei
adjuvant
immune responses
title Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
title_full Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
title_fullStr Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
title_full_unstemmed Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
title_short Immunostimulatory activity of exopolysaccharides from probiotic Lactobacillus casei WXD030 strain as a novel adjuvant in vitro and in vivo
title_sort immunostimulatory activity of exopolysaccharides from probiotic lactobacillus casei wxd030 strain as a novel adjuvant in vitro and in vivo
topic exopolysaccharides
lactobacillus casei
adjuvant
immune responses
url http://dx.doi.org/10.1080/09540105.2018.1513994
work_keys_str_mv AT leixiu immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT haochizhang immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT zhongpenghu immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT yanchenliang immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT shuaiguo immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT mingyang immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT ruipingdu immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo
AT xiaowang immunostimulatoryactivityofexopolysaccharidesfromprobioticlactobacilluscaseiwxd030strainasanoveladjuvantinvitroandinvivo